arrow
Back
R

Richard G. Langley

Dalhousie University

77H-index
409Paper Count
2.7WCitation Count
Published Papers 176
Publication Date
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND
err2026-02-05
err0
errOAAI
errAndrew Blauvelt; H. Chih-Ho Hong; Norito Katoh; Richard G. Langley; Vivian Laquer; Aleksandra Lesiak; Ketty Peris; Julien Seneschal; Juan-Francisco Silvestre; Richard B. Warren; Andreas Wollenberg; Matthew Zirwas; Niels Højsager Bennike; Farzaneh Safavimanesh; Ann-Marie Tindberg; Kristian Reich
errShare
errSave
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals
err2025-11-22
err0
errOAAI
errRaymond Matthews; April W. Armstrong; Matthias Augustin; Christopher Baker; José Manuel Carrascosa; Brian Kirby; Richard Langley; Sandy McBride; Adam Reich; Ricardo Romiti; Francesca Sampogna; Richard B. Warren
errShare
errSave
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis
err2025-11-01
err1
errOAAI
errGooderham, Melinda; Ameen, Mahreen; Hong, H. Chih-ho; Katoh, Norito; Langley, Richard G.; Peris, Ketty; Reich, Kristian; Silvestre, Juan F.; Simpson, Eric; Werfel, Thomas; Gjerum, Le; Tindberg, Ann-marie; Oland, Christian Bjerregard; Blauvelt, Andrew
errShare
errSave
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials
err2025-11-01
err1
errOAAI
errReich, Kristian; Langley, Richard G.; Silvestre Salvador, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew E.; Paller, Amy S.; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Blauvelt, Andrew; Bjerregard Oland, Christian; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric L.
errShare
errSave
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement
err2025-10-01
err1
errOAAI
errGold, Linda Stein; Gottlieb, Alice B.; Armstrong, April W.; Alkousakis, Theodore; Bissonnette, Robert; Langley, Richard G.; Krueger, James; Papp, Kim; Choi, Olivia; Rowland, Katelyn; Chan, Daphne; Jeyarajah, Jenny; Park-Wyllie, Laura; Gao, Long-Long; Gordon, Kenneth B.; Merola, Joseph F.; Lebwohl, Mark G.; Strober, Bruce
errShare
errSave
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults
err2025-09-24
err0
errOAAI
errRichard G. Langley; Guy Gherardi; Anna Coleman; Marius Ardeleanu; Ainara Rodríguez-Marco; Stephane Levy; Ashish Bansal; Zhen Chen; Ana B. Rossi; Brad Shumel; Faisal A. Khokhar
errShare
errSave
Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-Analysis
err2025-07-17
err0
errOAAI
errKim A. Papp; Ron Vender; Kerri Purdy; Fiona Lovegrove; Irina Oroz; Parbeer Grewal; Perla Lansang; Laura Park-Wyllie; Nastaran Abbarin; Ya-Wen Yang; Becky Hooper; Sandra Vigelis; Tim Disher; Richard G. Langley
errShare
errSave
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial
err2025-04-24
err0
errOAAI
errAndrew Blauvelt; Richard G. Langley; Mark Lebwohl; Bruce Strober; Richard B. Warren; Luis Puig; Akimichi Morita; Kenneth B. Gordon; Pablo Fernandez-Peñas; Sarah Kavanagh; José M. López Pinto; Jérémy Lambert; Bengt Hoepken; Delphine Deherder; Nancy Cross; Diamant Thaçi
errShare
errSave
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector
err2025-03-01
err0
errOAAI
errSebastian, Michael; Bagel, Jerry; Hoepken, Bengt; Knapp, Bertram; Bicer, Ceyhun; MacPherson, Merran; Langley, Richard G.
errShare
errSave
Mission impossible? Caveats in interpreting and comparing long-term efficacy in biologic studies for moderate-to-severe plaque psoriasis
err2025-02-22
err0
PREAI
errRichard G. Langley; Alexander Egeberg; Melinda Gooderham; Robert Bissonnette; Julien Ringuet; Sunil Kalia; Laura Park-Wyllie; Nastaran Abbarin
errShare
errSave
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)
err2025-01-07
err2
PREAI
errSilverberg, Jonathan, I; Eichenfield, Lawrence F.; Blauvelt, Andrew; Irvine, Alan D.; Guttman-Yassky, Emma; Langley, Richard G.; Warren, Richard B.; French, Lars E.; Felding, Jakob; Weiss, Anne; Pedersen, Claus B.; Jensen, Morten L.; Carlsson, Anna; Sommer, Morten O. A.; Kjoller, Kim; Simpson, Eric L.
errShare
errSave
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus
err2024-08-16
err0
PREAI
errTorres, T.; Brembilla, N. C.; Langley, R. G.; Warren, R. B.; Thaci, D.; Kolios, A. G. A.; Prinz, J. C.; Londono-Garcia, A.; Nast, A.; Santin, M.; Goletti, D.; Abreu, M.; Spuls, P.; Boehncke, W. H.; Puig, L.
errShare
errSave
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials
err2024-08-08
err0
PREAI
errReich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric
errShare
errSave
Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)
err2024-08-08
err0
PREAI
errSilverberg, Jonathan; Eichenfield, Lawrence; Blauvelt, Andrew; Irvine, Alan D.; Langley, Richard; Guttman, Emma; Warren, Richard; French, Lars; Pedersen, Claus Bang; Carlsson, Anna; Jensen, Morten Lind; Sommer, Morten O. A.; Kjoller, Kim; Simpson, Eric
errShare
errSave
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
err2024-06-01
err0
PREAI
errChat, Vipawee S.; Ellebrecht, Christoph T.; Kingston, Paige; Gondo, George; Bell, Stacie; Cordoro, Kelly M.; Desai, Seemal R.; Duffin, Kristina C.; Feldman, Steven R.; Garg, Amit; Gelfand, Joel M.; Gladman, Dafna; Green, Lawrence J.; Gudjonsson, Johann; Han, George; Hawkes, Jason E.; Kircik, Leon; Koo, John; Langley, Richard; Lebwohl, Mark; Lewitt, G. Michael; Liao, Wilson; Martin, George; Orbai, Ana-Maria; Reddy, Soumya M.; Richardson, Veronica; Ritchlin, Christopher T.; Schwartzman, Sergio; Siegel, Evan L.; Van Voorhees, Abby S.; Wallace, Elizabeth B.; Weinberg, Jeffrey M.; Winthrop, Kevin L.; Yamauchi, Paul; Armstrong, April W.
errShare
errSave
BIMEKIZUMAB IMPACT ON CARDIOVASCULAR INFLAMMATION MARKERS IN MODERATE TO SEVERE PLAQUE PSORIASIS: RESULTS FROM PHASE 3 TRIALS
err2024-06-01
err0
PREAI
errKokolakis, G.; Warren, R. B.; Langley, R. G.; Kirby, B.; Krueger, J. G.; Eyerich, K.; Davis, L.; Davies, O.; Cross, N.; Deherder, D.; Strober, B.
errShare
errSave
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
err2024-03-01
err5
errOAAI
errWarren, Richard B.; French, Lars E.; Blauvelt, Andrew; Langley, Richard G.; Egeberg, Alexander; Mrowietz, Ulrich; Hunter, Hamish J. A.; Gooderham, Melinda; Soerensen, Per; Andres, Philippe; Sommer, Morten O. A.; Carlsson, Anna; Kjoller, Kim D.; Strober, Bruce E.
errShare
errSave
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials
err2024-02-07
err0
PREAI
errReich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric
errShare
errSave
Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control
err2024-02-07
err1
PREAI
errBlauvelt, Andrew; Langley, Richard G.; Peris, Ketty; Silvestre, Juan Francisco; Katoh, Norito; Tauber, Marie; Pinter, Andreas; Ameen, Mahreen; Gooderham, Melinda; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Reich, Kristian
errShare
errSave
Using Artificial Intelligence as a Melanoma Screening Tool in Self-Referred Patients
err2023-12-29
err6
errOAAI
errCrawford, Madeleine E.; Kamali, Kiyana; Dorey, Rachel A.; Macintyre, Olivia C.; Cleminson, Kristyna; Macgillivary, Michael L.; Green, Peter J.; Langley, Richard G.; Purdy, Kerri S.; Decoste, Ryan C.; Gruchy, Jennette R.; Pasternak, Sylvia; Oakley, Amanda; Hull, Peter R.
errShare
errSave